Point72 Asset Management L.P. bought a new position in shares of Immunovant, Inc. (NASDAQ:IMVT – Free Report) during the fourth quarter, Holdings Channel reports. The fund bought 2,666,883 shares of the company’s stock, valued at approximately $112,356,000. Other institutional investors and hedge funds also recently modified their holdings of the company. Headlands Technologies LLC acquired […]
Rhenman & Partners Asset Management AB decreased its position in shares of Immunovant, Inc. (NASDAQ:IMVT – Free Report) by 12.0% during the 4th quarter, HoldingsChannel.com reports. The fund owned 146,061 shares of the company’s stock after selling 20,000 shares during the period. Rhenman & Partners Asset Management AB’s holdings in Immunovant were worth $6,154,000 at […]
Immunovant, Inc. (NASDAQ:IMVT – Free Report) – Stock analysts at HC Wainwright issued their Q1 2026 earnings per share (EPS) estimates for Immunovant in a note issued to investors on Thursday, May 30th. HC Wainwright analyst D. Tsao forecasts that the company will post earnings of ($0.62) per share for the quarter. HC Wainwright has […]